145 related articles for article (PubMed ID: 23658934)
21. Double-hit lymphoma at second relapse of Burkitt-like lymphoma: a case report.
Tanaka H; Hashimoto S; Abe D; Sakai S; Takagi T
J Clin Exp Hematop; 2011; 51(1):43-7. PubMed ID: 21628860
[TBL] [Abstract][Full Text] [Related]
22. Double-Hit Lymphoma.
Goyal G; Caponetti GC; Silberstein PT
J Clin Exp Hematop; 2015; 55(1):51-3. PubMed ID: 26106008
[No Abstract] [Full Text] [Related]
23. MYC in diffuse large B-cell lymphoma: always the bad guy?
Kersten MJ; Guikema JE
Leuk Lymphoma; 2015; 56(11):3003-4. PubMed ID: 25944471
[No Abstract] [Full Text] [Related]
24. Diagnosis of 'double hit' diffuse large B-cell lymphoma and B-cell lymphoma, unclassifiable, with features intermediate between DLBCL and Burkitt lymphoma: when and how, FISH versus IHC.
Swerdlow SH
Hematology Am Soc Hematol Educ Program; 2014 Dec; 2014(1):90-9. PubMed ID: 25696840
[TBL] [Abstract][Full Text] [Related]
25. Triple-hit lymphoma with hyperbasophilic Burkitt-like morphology and solely bone marrow/leukemic phase presentation.
Ortuño FJ; Amigo ML
Blood; 2020 Sep; 136(10):1212. PubMed ID: 32882021
[No Abstract] [Full Text] [Related]
26. Aggressive B cell Lymphoma: Optimal Therapy for MYC-positive, Double-Hit, and Triple-Hit DLBCL.
Dunleavy K
Curr Treat Options Oncol; 2015 Dec; 16(12):58. PubMed ID: 26634708
[TBL] [Abstract][Full Text] [Related]
27. A peculiar case of precursor B lymphoblastic leukaemia/lymphoma histologically mimicking diffuse large B-cell lymphoma.
Tasaki K; Nakamura N; Hojo H; Yoshihisa A; Maruyama Y; Abe M
Histopathology; 2004 Jan; 44(1):83-4. PubMed ID: 14717676
[No Abstract] [Full Text] [Related]
28. [Fluorescence in situ hybridization in the diagnosis of aggressive B-cell lymphomas].
Gerhard-Hartmann E; Rosenwald A
Pathologe; 2020 Nov; 41(6):574-581. PubMed ID: 32909092
[TBL] [Abstract][Full Text] [Related]
29. [Successful treatment with dose-adjusted EPOCH-R for triple-hit lymphoma having BCL2, BCL6 and MYC translocations].
Hashimoto A; Fujimi A; Kanisawa Y; Nakajima C; Hayasaka N; Yamada S; Okuda T; Minami S; Matsumoto T; Shibata T; Hamaguchi K; Kamihara Y; Iwasaki S; Kato J
Rinsho Ketsueki; 2015 Jul; 56(7):905-10. PubMed ID: 26256929
[TBL] [Abstract][Full Text] [Related]
30. Composite diffuse large B-cell lymphoma and precursor B lymphoblastic lymphoma presenting as a double-hit lymphoma with MYC and BCL2 translocation.
Nanua S; Bartlett NL; Hassan A; Robirds D; Branson J; Frater JL; Nguyen TT; Kreisel F
J Clin Pathol; 2011 Nov; 64(11):1032-4. PubMed ID: 21778297
[No Abstract] [Full Text] [Related]
31. Coexistent rearrangements of c-MYC, BCL2, and BCL6 genes in a diffuse large B-cell lymphoma.
Ueda C; Nishikori M; Kitawaki T; Uchiyama T; Ohno H
Int J Hematol; 2004 Jan; 79(1):52-4. PubMed ID: 14979479
[TBL] [Abstract][Full Text] [Related]
32. Clinicopathological prognostic factors of 24 patients with B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma.
Miyamoto K; Kobayashi Y; Maeshima AM; Taniguchi H; Nomoto J; Kitahara H; Fukuhara S; Munakata W; Maruyama D; Tobinai K
Int J Hematol; 2016 Jun; 103(6):693-702. PubMed ID: 27095041
[TBL] [Abstract][Full Text] [Related]
33. MYC-associated and double-hit lymphomas: a review of pathobiology, prognosis, and therapeutic approaches.
Petrich AM; Nabhan C; Smith SM
Cancer; 2014 Dec; 120(24):3884-95. PubMed ID: 25060588
[TBL] [Abstract][Full Text] [Related]
34. Aggressive B-cell lymphomas with translocations involving BCL6 and MYC have distinct clinical-pathologic characteristics.
Turakhia SK; Hill BT; Dufresne SD; Nakashima MO; Cotta CV
Am J Clin Pathol; 2014 Sep; 142(3):339-46. PubMed ID: 25125624
[TBL] [Abstract][Full Text] [Related]
35. De novo acute B cell leukemia/lymphoma with t(14;18).
Stamatoullas A; Buchonnet G; Lepretre S; Lenain P; Lenormand B; Duval C; Callat MP; Gaulard P; Bastard C; Tilly H
Leukemia; 2000 Nov; 14(11):1960-6. PubMed ID: 11069032
[TBL] [Abstract][Full Text] [Related]
36. Adult B-cell lymphomas with burkitt-like morphology are phenotypically and genotypically heterogeneous with aggressive clinical behavior.
McClure RF; Remstein ED; Macon WR; Dewald GW; Habermann TM; Hoering A; Kurtin PJ
Am J Surg Pathol; 2005 Dec; 29(12):1652-60. PubMed ID: 16327438
[TBL] [Abstract][Full Text] [Related]
37. High-grade B-cell Lymphoma With MYC Rearrangement and Without BCL2 and BCL6 Rearrangements Is Associated With High P53 Expression and a Poor Prognosis.
Li S; Weiss VL; Wang XJ; Desai PA; Hu S; Yin CC; Tang G; Reddy NM; Medeiros LJ; Lin P
Am J Surg Pathol; 2016 Feb; 40(2):253-61. PubMed ID: 26448193
[TBL] [Abstract][Full Text] [Related]
38. Mediastinal large B-cell lymphoma: new evidence in support of its distinctive identity.
Chan JK
Adv Anat Pathol; 2000 Jul; 7(4):201-9. PubMed ID: 10907805
[No Abstract] [Full Text] [Related]
39. TP53 mutations are frequent events in double-hit B-cell lymphomas with MYC and BCL2 but not MYC and BCL6 translocations.
Gebauer N; Bernard V; Gebauer W; Thorns C; Feller AC; Merz H
Leuk Lymphoma; 2015 Jan; 56(1):179-85. PubMed ID: 24679006
[TBL] [Abstract][Full Text] [Related]
40. Triple-hit B-cell Lymphoma With MYC, BCL2, and BCL6 Translocations/Rearrangements: Clinicopathologic Features of 11 Cases.
Wang W; Hu S; Lu X; Young KH; Medeiros LJ
Am J Surg Pathol; 2015 Aug; 39(8):1132-9. PubMed ID: 25828391
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
